Takatsuki, Japan

Masayasu Enomoto


Average Co-Inventor Count = 1.3

ph-index = 6

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 1986-1998

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Masayasu Enomoto: Innovator in Fibrinogen Determination

Introduction

Masayasu Enomoto is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the determination of fibrinogen and antithrombin III activity. With a total of 7 patents to his name, Enomoto's work has had a considerable impact on clinical practices.

Latest Patents

One of Enomoto's latest patents is a method for determining fibrinogen concentration. This innovative approach involves adding thrombin or a protease inhibitor to an undiluted test sample, converting fibrinogen into fibrin. The determination of coagulation time occurs in a reaction mixture containing a high concentration of salt, allowing for simplified testing without the need to dilute the sample. Another significant patent is the method for determining antithrombin III activity, along with a reagent kit designed for this purpose.

Career Highlights

Throughout his career, Enomoto has worked with prominent companies such as Nippon Shoji Kaisha Ltd. and Nippon Shoji Kabushiki Kaisha. His expertise in medical diagnostics has positioned him as a key figure in the development of innovative testing methods.

Collaborations

Enomoto has collaborated with notable colleagues, including Masahiro Yamaguchi and Masaharu Takayama. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Masayasu Enomoto's contributions to the field of medical diagnostics through his innovative patents have significantly enhanced the accuracy and efficiency of fibrinogen and antithrombin III determination. His work continues to influence clinical practices and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…